YIH
NVO

Y-Intercept (HK)’s Novo Nordisk NVO Stock Holding History

Y-Intercept (HK)’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.12M Sell
86,018
-79,963
-48% -$3.44M 0.08% 343
2026
Q1 		$6.1M Buy
165,981
+134,095
+421% +$6.35M 0.12% 256
2025
Q4 		$1.62M Buy
31,886
+10,641
+50% +$544K 0.04% 725
2025
Q3 		$1.18M Buy
21,245
+10,577
+99% +$619K 0.03% 898
2025
Q2 		$736K Sell
10,668
-237,147
-96% -$16.1M 0.02% 1071
2025
Q1 		$17.2M Buy
247,815
+122,734
+98% +$10.1M 1.17% 1
2024
Q4 		$10.8M Buy
125,081
+83,364
+200% +$9.01M 0.72% 7
2024
Q3 		$4.97M Buy
+41,717
New +$5.56M 0.3% 48
2024
Q2 		– Sell
-16,192
Closed -$2.08M – 1759
2024
Q1 		$2.08M Sell
16,192
-9,238
-36% -$1.1M 0.16% 162
2023
Q4 		$2.63M Buy
25,430
+1,778
+8% +$176K 0.24% 92
2023
Q3 		$2.15M Buy
23,652
+3,894
+20% +$343K 0.21% 126
2023
Q2 		$1.6M Buy
+19,758
New +$1.61M 0.17% 150
2022
Q3 		– Sell
-18,556
Closed -$1.03M – 1183
2022
Q2 		$1.03M Buy
+18,556
New +$1.03M 0.14% 218
2021
Q4 		– Sell
-49,664
Closed -$2.38M – 792
2021
Q3 		$2.38M Buy
+49,664
New +$2.4M 0.43% 43
2021
Q2 		– Sell
-18,478
Closed -$628K – 811
2021
Q1 		$628K Buy
18,478
+9,494
+106% +$338K 0.17% 193
2020
Q4 		$315K Buy
+8,984
New +$311K 0.13% 297

Other funds holding NVO

SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Y-Intercept (HK)'s NVO Position: Q2 2026 in Review

Y-Intercept (HK) reduced its Novo Nordisk (NVO) stake by 48% in Q2 2026, selling an estimated $3.44M and leaving 86,018 shares worth $4.12M. The position accounts for 0.08% of the portfolio, ranked #343.

Y-Intercept (HK) first reported a position in NVO in Q4 2020 and has held it in 16 quarters since. The position peaked at $17.2M in Q1 2025. 292 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Y-Intercept (HK) held 86,018 shares of Novo Nordisk worth $4.12M as of Q2 2026.
  • Y-Intercept (HK) sold 79,963 Novo Nordisk shares in Q2 2026, an estimated $3.44M.
  • Novo Nordisk made up 0.08% of Y-Intercept (HK)'s portfolio in Q2 2026, its #343 holding.
  • Y-Intercept (HK) first reported a position in Novo Nordisk in Q4 2020 and has held it in 16 quarters since.
  • Y-Intercept (HK)'s Novo Nordisk position peaked at $17.2M in Q1 2025.
  • 292 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.